Update on the management of diabetes in long-term care facilities

被引:10
作者
Idrees, Thaer [1 ]
Castro-Revoredo, Iris A. [1 ]
Migdal, Alexandra L. [1 ]
Moreno, Emmelin Marie [1 ]
Umpierrez, Guillermo E. [1 ]
机构
[1] Emory Univ, Dept Med, Div Endocrinol, Atlanta, GA 30322 USA
关键词
hypoglycemia; diabetes mellitus; type; 1; 2; geriatrics; DIPEPTIDYL PEPTIDASE-4 INHIBITOR; CLINICAL-PRACTICE GUIDELINES; EMERGENCY-DEPARTMENT VISITS; RANDOMIZED CONTROLLED-TRIAL; MULTIPLE CHRONIC CONDITIONS; SKILLED NURSING FACILITIES; COTRANSPORTER; INHIBITORS; HOSPITALIZED-PATIENTS; ELDERLY-PATIENTS; OLDER-ADULTS;
D O I
10.1136/bmjdrc-2021-002705
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The number of patients with diabetes is increasing among older adults in the USA, and it is expected to reach 26.7 million by 2050. In parallel, the percentage of older patients with diabetes in long-term care facilities (LTCFs) will also rise. Currently, the majority of LTCF residents are older adults and one-third of them have diabetes. Management of diabetes in LTCF is challenging due to multiple comorbidities and altered nutrition. Few randomized clinical trials have been conducted to determine optimal treatment for diabetes management in older adults in LTCF. The geriatric populations are at risk of hypoglycemia since the majority are treated with insulin and have different levels of functionality and nutritional needs. Effective approaches to avoid hypoglycemia should be implemented in these settings to improve outcome and reduce the economic burden. Newer medication classes might carry less risk of developing hypoglycemia along with the appropriate use of technology, such as the use of continuous glucose monitoring. Practical clinical guidelines for diabetes management including recommendations for prevention and treatment of hypoglycemia are needed to appropriately implement resources in the transition of care plans in this vulnerable population.
引用
收藏
页数:14
相关论文
共 208 条
  • [61] Filippatos Theodosios D, 2014, Rev Diabet Stud, V11, P202, DOI 10.1900/RDS.2014.11.202
  • [62] Glucagon rDNA origin (GlucaGen®) and Recombinant LH (No. 12 in a series of articles to promote a better understanding of the use of genetic engineering)
    Fonjallaz, P
    Loumaye, E
    [J]. JOURNAL OF BIOTECHNOLOGY, 2000, 79 (02) : 185 - 189
  • [63] Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus
    Fonseca, VA
    Kelley, DE
    Cefalu, W
    Baron, MA
    Purkayastha, D
    Nestler, JE
    Hsia, S
    Gerich, JE
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (10): : 1331 - 1335
  • [64] The GesTIO protocol experience: safety of a standardized order set for subcutaneous insulin regimen in elderly hospitalized patients
    Franchin, Alessandro
    Maran, Alberto
    Bruttomesso, Daniela
    Corradin, Maria L.
    Rossi, Francesco
    Zanatta, Federica
    Barbato, Gian-Maria
    Sicolo, Nicola
    Manzato, Enzo
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2017, 29 (06) : 1087 - 1093
  • [65] DIABETES CARE POLICIES AND PRACTICES IN MICHIGAN NURSING-HOMES, 1991
    FUNNELL, MM
    HERMAN, WH
    [J]. DIABETES CARE, 1995, 18 (06) : 862 - 866
  • [66] Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic
    Galindo, Rodolfo J.
    Aleppo, Grazia
    Klonoff, David C.
    Spanakis, Elias K.
    Agarwal, Shivani
    Vellanki, Priya
    Olson, Darin E.
    Umpierrez, Guillermo E.
    Davis, Georgia M.
    Pasquel, Francisco J.
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (04): : 822 - 832
  • [67] CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM-2018 EXECUTIVE SUMMARY
    Garber, Alan J.
    Abrahamson, Martin J.
    Barzilay, Joshua I.
    Blonde, Lawrence
    Bloomgarden, Zachary T.
    Bush, Michael A.
    Dagogo-Jack, Samuel
    DeFronzo, Ralph A.
    Einhorn, Daniel
    Fonseca, Vivian A.
    Garber, Jeffrey R.
    Garvey, W. Timothy
    Grunberger, George
    Handelsman, Yehuda
    Hirsch, Irl B.
    Jellinger, Paul S.
    McGill, Janet B.
    Mechanick, Jeffrey I.
    Rosenblit, Paul D.
    Umpierrez, Guillermo E.
    [J]. ENDOCRINE PRACTICE, 2018, 24 (01) : 91 - 120
  • [68] National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations
    Geller, Andrew I.
    Shehab, Nadine
    Lovegrove, Maribeth C.
    Kegler, Scott R.
    Weidenbach, Kelly N.
    Ryan, Gina J.
    Budnitz, Daniel S.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (05) : 678 - 686
  • [69] Diabetes care in rest homes in Christchurch, New Zealand
    Gill, E. A.
    Corwin, P. A.
    Mangin, D. A.
    Sutherland, M. G.
    [J]. DIABETIC MEDICINE, 2006, 23 (11) : 1252 - 1256
  • [70] Efficacy of SGLT-2 inhibitors in older adults with diabetes: Systematic review with meta-analysis of cardiovascular outcome trials
    Giugliano, Dario
    Longo, Miriam
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Chiodini, Paolo
    Solerte, Sebastiano Bruno
    Esposito, Katherine
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162